the SRIW Life Sciences
3
22M
2
1
0.33
- Areas of investment
Summary
We can highlight the next thriving fund investment areas, such as Biopharma, Life Science. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight A-Mansia Biotech.
The important activity for fund was in 2018. The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The standard case for the fund is to invest in rounds with 5 partakers. Despite the the SRIW Life Sciences, startups are often financed by Wallonia Regional Government. The meaningful sponsors for the fund in investment in the same round are Seventure Partners, Pierre Drion, Nivelinvest.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 1
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (3)
- Therapeutics (2)
- Medical (2)
- Health Care (2)
- Life Science (1) Show 2 more
- Investments by region
-
- Belgium (3)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Novadip Biosciences | 03 Nov 2022 | Biotechnology, Health Care, Medical, Therapeutics | Early Stage Venture | 28M | Walloon Brabant, Belgium, Belgium |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.